Insights

Explore our thought
leadership

Featured

Kx Advisors Spotlight: Dr. Sam Eaton

Kx Advisors Spotlight: Dr. Sam Eaton Finding Answers To Big Questions Dr. Sam Eaton, Kx Senior Consultant, is a problem solver by nature. His drive to find answers drew him to academia and to earn a PhD in Cardiovascular Pharmacology at the University of North Carolina. During his doctoral studies Sam immersed himself in understanding […]

Sam Eaton

World Map Showing Why Companies Need Global Strategy

Featured

Why Your Orphan Drug Needs A Global Market Access Strategy

An effective market access strategy for orphan drugs must be globally focused and adaptable to different regions to be effective. Our experts dissect the questions and considerations key to building one.

Jenna Riffell and Sean Vander Linde

Blogs and publications
by sector

Blog Posts

Kx Advisors Spotlight: Dr. Sam Eaton

August 18, 2020 • Kx Advisors Spotlight: Dr. Sam Eaton Finding Answers To Big Questions Dr. Sam Eaton, Kx Senior Consultant, is a problem solver by nature. His drive to find answers drew him to academia and to earn a PhD in Cardiovascular Pharmacology at the University of North Carolina. During his doctoral studies Sam immersed himself in understanding […]

Sam Eaton

Why Your Orphan Drug Needs A Global Market Access Strategy

July 9, 2020 • An effective market access strategy for orphan drugs must be globally focused and adaptable to different regions to be effective. Our experts dissect the questions and considerations key to building one.

Jenna Riffell and Sean Vander Linde

Map Showing COVID-19 Best Strategies For Medical Practices Pain Points and Solutions

How Medical Practices Can Keep Patients Safe: COVID-19 Best Strategies

June 9, 2020 • As COVID restrictions are rolled back, medical practices can implement practices to keep both staff and patients safe. Our experts outline COVID-19 best strategies based on direct feedback from physicians.

Chris Waybill and Jason Shim

COVID-19 Pipeline Prioritization Business Meeting

How Does COVID-19 Change Clinical Pipeline Prioritization?

May 28, 2020 • Our experts break down both the challenges healthcare organizations face due to COVID-19 and the considerations they must analyze as they assess and adapt their strategic pipeline.

Brett Larson

Elective Procedures Doctor Putting On Gloves

Elective Procedures After COVID-19: How To Support Rebounding Demand

May 22, 2020 • Our experts dissect elective procedures COVID-19 restrictions and explore how procedure-focused companies can support rebounding demand.

Jenna Riffell

COVID 19 Market Research Target Stakeholders

Should You Do Market Research During COVID-19?

April 22, 2020 • Healthcare leaders are asking: is now a good time to do market research given COVID-19? Our experts answer with an enthusiastic yes. Find out what kinds of research to perform and avoid during the pandemic.

Sean Vander Linde

COVID-19 Product Forecasting Framework Graphic Depicting Trough and Rebound

Adapting In COVID-19: A Product Forecasting Framework

April 13, 2020 • With patients depending on healthcare companies for life-changing medications and devices, accurate forecasting to respond to the evolving COVID-19 challenges is paramount. Our framework can help product teams adjust appropriately.

Sean Vander Linde and Jenna Riffell

Launch Planning Framework For Product Managers During COVID-19

3 Questions To Ask For Launch Planning During COVID-19

March 27, 2020 • Pharmaceuticals and medical device companies must act quickly to adapt product launch plans. See our team’s framework for product managers facing this pandemic.

Evelyn Tee

Graph depicting degree of impact on procedures based on setting and urgency

How Is COVID-19 Impacting Procedure Volume?

March 27, 2020 • Learn how COVID-19 is impacting procedure volume within the orthopedic field and what insights companies in other fields can leverage to adjust their strategic plans.

Jenna Riffell